United States · FDA National Drug Code directory
Xeomin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46783-165_8b2d961a-6bb4-4bef-ac07-7dcc2bbfacc7
- Product NDC
- 46783-165
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- incobotulinumtoxinA
- Labeler
- Merz North America, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20110801
- Source listing expiry
- 20271231
Source-listed ingredients
- BOTULINUM TOXIN TYPE A — 50 [USP'U]/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (46783-165-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE · 46783-165-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →